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The molecular mechanisms leading to epithelial
metaplasias are poorly understood. Barrett’s esoph-
agus is a premalignant metaplastic change of the
esophageal epithelium into columnar epithelium,
occurring in patients suffering from gastroesopha-
geal reflux disease.Mechanisms behind the develop-
ment of the intestinal subtype, which is associated
with the highest cancer risk, are unclear. In humans,
it hasbeensuggested that anonspecializedcolumnar
metaplasia precedes the development of intestinal
metaplasia. Here, we propose that a complex made
up of at least two factors needs to be activated sim-
ultaneously to drive the expression of intestinal type
of genes. Using unique animal models and robust
in vitro assays, we show that the nonspecialized
columnarmetaplasia is aprecursor of intestinalmeta-
plasia and that pSMAD/CDX2 interaction is essential
for the switch toward an intestinal phenotype.INTRODUCTION
Barrett’s esophagus (BE) is defined as the replacement of
normal stratified squamous epithelium with columnar epithelium
in the distal part of the esophagus. This metaplastic columnar
epithelium can be classified into various types depending on
specific histological features. The most common are several
nonintestinal and the specialized intestinal type of columnar
metaplasia; the latter is also referred to as intestinal metaplasia
(IM). IM is associated with a higher risk of developing esophageal
adenocarcinoma (EAC) (Chandrasoma et al., 2007). BE develops
in 15%–20% of patients suffering from chronic gastroesopha-
geal reflux disease (Spechler et al., 2010). Currently, there are
no robust molecular biomarkers to detect disease and predict
progression, whereas there is no molecular cure for BE. This
would require a much greater understanding of the molecular
events involved in the process of metaplasia.CRecently, there has been more focus on the role of transcrip-
tion factors in the development of metaplasia. These factors
include the caudal-related homeobox family members Caudal
type Homeobox 1 (CDX1) and Caudal type Homeobox 2
(CDX2) (Huo et al., 2010; Kazumori et al., 2006, 2009), factors
such as GATA binding protein 4 (GATA4) (Chen et al., 2008),
GATA binding protein 6 (GATA6) (Wang et al., 2009), Hypoxia-
inducible factor 1 alpha (HIF-1alpha), Hypoxia-inducible factor
2 alpha (HIF-2alpha) (Griffiths et al., 2007), SRY (sex determining
region Y)-box 9 (SOX9) (Wang et al., 2010; Clemons et al., 2012),
Kruppel-like factor 4 (KLF4) (Kazumori et al., 2011), and HOX
genes (di Pietro et al., 2012). However, in vivo confirmation of
their importance is rather limited. Overexpression of CDX2 in
the mouse esophagus under the cytokeratin 14 (K14) promoter
failed to induce columnar metaplasia (Kong et al., 2011),
suggesting that CDX2 alone is insufficient to induce columnar
metaplasia, unlike the metaplasia of the stomach, where overex-
pression of CDX2 under theH+/K+ATPase promoter clearly leads
to intestinal metaplasia of the stomach (Mutoh et al., 2002).
A number of morphogens have also been identified as impor-
tant contributors to BE pathogenesis. Our group has shown that
in vitro stimulation of esophageal cells with BoneMorphogenetic
Protein 4 (BMP4) and activation of its downstream target phos-
phorylated mothers against decapentaplegic 1/5/8 (pSMAD1/
5/8; pSMAD) induces the expression of columnar type of genes
but does not lead to IM (Milano et al., 2007). Others have shown
that overexpression of Sonic Hedgehog (Shh) induces BMP4 in
the stroma, which upregulates SOX9 and columnar cytokeratins
in the epithelium (Wang et al., 2010). All these studies identify
certain factors that are necessary for the development of the
columnar epithelium, but none of these individual factors is suf-
ficient for the development of IM suggesting that other mecha-
nisms are involved.
In the current study, we observed that in vivo overexpression
of BMP4 induces a columnar phenotype. Similar to the nonintes-
tinal type of columnar metaplasia observed in humans (Nemeth
et al., 2012), these glands express pSMAD and several columnar
markers; however, they lack expression of IM markers such as
CDX2 andMucin 2 (MUC2) (Mesquita et al., 2003). In a microsur-
gical murine model, we demonstrate the sequential process ofell Reports 7, 1197–1210, May 22, 2014 ª2014 The Authors 1197
Figure 1. Characterization of K14-BMP4
Mouse
(A) Bmp4 cDNA was subcloned into the K14-hGH
polyA plasmid.
(B) Genotyping PCR for K14-BMP4 fragment.
(C) Western blot expression of BMP4 in the
esophagus of wild-type (WT) and K14-BMP4
mice.
(D) Hematoxylin and eosin (H&E), BMP4, and
pSMAD staining of WT and K14-BMP4 mice
esophagi (scale bar, 200 mm).
See also Figure S1.nonspecialized columnar metaplasia that develops as a precur-
sory lesion and leads to the development of IM, where coexpres-
sion of pSMAD, CDX2, and MUC2 are observed. From in vitro
experiments, we found a synergistic collaboration between the
two nuclear transcription factors CDX2 and pSMAD, which
drives development of an intestinal phenotype in epithelial cells.
These findings provide insights in the development of the prema-
lignant IM and reveal key molecular targets for developing novel
preventive treatments.
RESULTS
BMP4Activation Is Required for ColumnarMetaplasia at
the Squamocolumnar Junction but Is Not Sufficient for
Intestinal Metaplasia in a Transgenic Mouse Model
Murine Bmp4 cDNA was subcloned into the K14-hGH poly (A)
plasmid (Figure 1A) and injected into CB6F1 one-cell embryos
to generate the K14-BMP4 mice (Guha et al., 2002) (Figure 1B).
The esophageal epithelium of the BMP4mouse compared to the1198 Cell Reports 7, 1197–1210, May 22, 2014 ª2014 The Authorswild-type controls revealed vacuolization
of nuclei and a widened zona spinosum,
indicating ‘‘delayed’’ keratinization of
the cells (Figures 1D, H&E). Immuno-
histochemistry (IHC) showed increased
expression of BMP4 (Figure 1D) in the
basal and suprabasal cells and excreted
BMP4 in the intercellular space between
the nonkeratinizing and keratinizing
layers. Nuclear expression of pSMAD,
the downstream target of BMP4, was
increased in the transgenic animals,
whereas only weakly positive in the
wild-type (Figure 1D). We also noticed
that the K14-BMP4 mice had increased
expression of Noggin, a natural inhibitor
of BMPs, in the underlying stroma and
muscularis mucosa as compared to
the wild-type. Noggin expression was
highest in the proximal tubular esoph-
agus as compared to the fore-stomach
(Figure S1).
In 20-week-old animals, we observed
the spontaneous appearance of col-
umnar glandular structures at the squa-mocolumnar junction (SCJ) in the fore-stomach of the transgenic
animals (Figure 2A). IHC on these glandular structures showed
positive staining for the squamous markers, cytokeratin 14
(K14), cytokeratin 5 (K5), and p63 (Figures 2Bi, ii, and iii) as
well as for the columnar markers pSMAD (Figure 2Biv), cytoker-
atin 19 (K19) (Figure 2Bv), and cytokeratin 8 (K8) (Figure S2A).
These partially multilayered glands are positive for Alcian blue
(Figure 2Bvi) and weakly positive for Trefoil Factor 2 (TFF2)
(Figure 2Bvii) but are negative for MUC5AC, MUC2, and CDX2
(Figure S2A). These glands are negative for the protein H+/
K+ATPase pump (Figure S2A), confirming the lack of parietal
cells. The basal layer of both the esophagus and the metaplastic
glands is positive for K14 and pSMAD (Figure S2B).
To understand the origin of the glands in our model, we per-
formed IHC for cell markers of both the squamous epithelium
and columnar/gastric cardia. Figure 2B shows that these glands
contain a subset of cells positive for the squamous stem cell
marker p63 (Senoo et al., 2007; Yang et al., 1999), and another
subset of cells is strongly positive for K19 and weak for TFF2,
Figure 2. Characterization of Metaplastic
Glands at the SCJ in the Fore-stomach of
K14-BMP4 Mice
(A) (i) Anatomical overview of the dissected mouse
esophagus and stomach, containing the proximal
stomach (PS), which is lined with squamous
epithelium, the distal stomach (DS), which has
columnar glands with parietal cells and the squa-
mocolumnar junction (SCJ). (ii) H&E of the SCJ
of WT and (iii) K14-BMP4 mice. Metaplastic
columnar glands at the SCJ in the transgenic
animals (arrows) (scale bar, 500 mm).
(B) IHC of glands at the SCJ of the K14-BMP4
mouse show cells with expression of squamous
markers K14 (i), K5 (ii), and p63 (iii) along with
columnar markers K19 (v), pSMAD (iv), Alcian blue
(vi), TFF2 (vii), andMUC5AC (viii). RNA ISH for Lgr5
in the metaplastic glands (closed arrows) along
with a normal adjacent cardia gland (open arrows)
(ix). Scale bar, 200 mm.
See also Figure S2.which aremarkers shown to label gastric progenitor cells (Means
et al., 2008; Quante et al., 2010). RNA in situ hybridization for the
intestinal stem cell marker Lgr5 (Barker et al., 2007), known to be
expressed in BE (Becker et al., 2010), was positive for a subset of
cells in these glands (Figure 2Bix).
In conclusion, the glands seen in this transgenic model include
a mixture of cell lineages and resemble the nonspecialized
columnar epithelium (NSCE) observed in humans (Glickman
et al., 2001a; Chaves et al., 2002; Srivastava et al., 2007). Earlier
studies in humans have suggested that a transitional multi-
layered epithelium and NSCE may indicate stages between
squamous and intestinal metaplasia (Chandrasoma, 1997). Our
findings suggest that BMP4 is important in the initiation of the
metaplastic process that leads to NSCE at the SCJ in the fore-
stomach of BMP4-overexpressing mice but is insufficient for
an intestinal phenotype.
pSMAD, CDX2, and MUC2 Are Expressed in Intestinal
Metaplasia, which Appears Only at a Later Stage in a
Surgical Reflux Mouse Model
Because BMP4 is insufficient to induce IM, we aimed to identify
the different stages at which important markers for IM including
CDX2 and MUC2 (Steininger et al., 2005) appear by using a
microsurgical mouse model. In this model, reflux and subse-
quently metaplasia of the esophageal mucosa is induced viaCell Reports 7, 1197–121an esophageal-jejunostomy following a
novel method (N.S. Buttar and C.J. De-
Mars, 2011, Digestive Disease Week,
abstract).
At week 12, this mouse model de-
velops a transitional zone at the anasto-
mosis site, the neosquamocolumnar
junction (neoSCJ), with metaplastic
columnar epithelium appearing distally
of the neoSCJ and in between the in-
flamed squamous epithelium (Figure 3A).The columnar epithelium in this zone resembles the nonspecial-
ized columnar type of epithelia as seen in BE patients (Fig-
ure S3B) and as described earlier (Srivastava et al., 2007). At
week 12 (Figure 3B), the inflamed squamous and themetaplastic
columnar epithelia express high levels of pSMAD. Only a few
columnar cells exhibit nuclear CDX2 expression, whereas the
expression of MUC2 is virtually absent. At week 16, the meta-
plastic columnar zone has expanded and exhibits more glands
and villi with histological features that increasingly resemble
the human type of IM (Figures S3B) (Srivastava et al., 2007).
Besides the high nuclear expression of pSMAD, the intestinal
metaplasia also shows high CDX2 expression along with the
expression of MUC2 (Figure 3B). Additionally, PAS staining is
positive, suggesting the presence of mucin producing cells
(Figure S3A).
These observations indicate that in the surgical model the
development of IM requires a stepwise series of events in which
a nonintestinal type of metaplasia resembling the human NSCE
precedes the development of IM.
Glands in the Surgical Metaplasia Model Do Not Arise
from Lgr5+ Progenitor Cells
Because Lgr5-expressing cells have been observed in human
BE, it has been suggested that the stem cells that give rise to
BE may originate from the neighboring columnar epithelia0, May 22, 2014 ª2014 The Authors 1199
Figure 3. Expression of Epithelial Markers and Lineage Tracing Results during Metaplasia Development in the Esophagus in a Surgical
Mouse Model
(A) Mouse model following Buttar’s esophagojejunostomy shows the positioning of two magnets. After 6 weeks, an esophageal-jejunal fistula is formed allowing
reflux of bile into the esophagus (red line). Right upper panel shows higher magnification of middle upper panel. H&E staining representative of the neo-SCJ at 6,
12, and 16 weeks postsurgery. The dotted black line indicates the anastomosis, and the double-headed arrows indicate the metaplastic area. Scale bar, 500 mm.
(B) H&E and IHC of inflamed squamous and metaplastic region for pSMAD, CDX2, and MUC2 at 12 and 16 weeks after surgery. Arrows indicate MUC2-positive
cells. Scale bar, 500 mm.
(C) Representative images of b-gal staining in Lgr5-cre-Rosa26-lacZ mice. The black dotted line indicates the metaplastic glands at the anastomosis site in the
esophagus 12 weeks after surgery. Scale bar, 500 mm.
See also Figures S2 and S3.
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Figure 4. qPCR Indicates that BMP4 Regu-
lates Expression of Epithelial Markers,
whereas BMP4 and CDX2 Induce MUC2
Expression
(A) Expression of columnar and squamous specific
genes in squamous and BE patient biopsies by
real-time qPCR arrays. Data are representative of
two independent experiments with two technical
replicates and were normalized to the expression
level of HPRT1.
(B and C) Expression of the same set of genes
in EPC2-hTERT and HET-1A cells under four
conditions: Control (unstimulated/untransfected),
transfected with CDX2, stimulated with BMP4
(100 ng/ml for 48 hr), transfected with CDX2, and
stimulated with BMP4. Results are expressed
relative to the baseline expression levels of the
control cells EPC2-hTERT or HET-1A (Figure S4).
Error bars indicate the SEM of the mean. Paired
t test *p < 0.05, **p < 0.01, ***p < 0.001, n = 4. See
also Figure S4.harboring Lgr5+ stem cells (Quante et al., 2012; Becker et al.,
2010; von Rahden et al., 2011). To investigate if the metaplasia
observed in the esophagus in our surgical model originates
from Lgr5+ progenitor cells, we performed lineage tracing
by creating the esophagojejunostomy in Lgr5-EGFP-ires-
CreERT2/Rosa26-lacZ mice (n = 15) (Barker et al., 2007). The
anastomosis was performed 1 week after administering Tamox-
ifen, and metaplasia was allowed to develop over 6 (n = 5), 12
(n = 5), and 16 weeks (n = 5). In this model, the progeny of
Lgr5+ stem cells will retain and express the lacZ gene, which
after exposure to b-galactosidase (b-gal) will turn blue. None of
the glands in all the animals studied showed positive b-gal stain-
ing, although the normal jejunum lying adjacent to the site of the
metaplasia showed entire blue crypts and villi indicating suc-
cessful lineage tracing in the jejunum (Figure 3C). Our data sug-
gest that Lgr5+ progenitors are not at the basis of the columnar
metaplasia that develops in the tubular esophagus and at the
neo-SCJ in our surgical model.Cell Reports 7, 1197–121BMP4 Stimulation of CDX2-
Transfected Cells Induces the
Expression of Intestinal Type of
Genes
Based on previous gene profiling studies,
we selected a panel of squamous genes:
Periplakin (PPL), cornulin (CRNN), cyto-
keratin 13 (K13), cytokeratin 5 (K5), and
columnar genes: Villin 1 (VIL1), carbonic
anhydrase I (CA1), apolipoprotein B
(APOB), TFF3, gap junction protein beta
1 (GJB1), cytokeratin 7 (K7), fatty acid
binding protein 6 (FABP6), acetyl-CoA
acetyltransferase 2 (ACAT2), and putative
CDX2 target genes:MUC2 and cytokera-
tin 20 (K20) that are known to be ex-
pressed in BE (Milano et al., 2007; van
Baal et al., 2013; Liu et al., 2007). Weanalyzed their basal gene expression levels in esophageal
biopsies from patients with and without BE, and in the human
squamous esophageal epithelial cell lines HET-1A and EPC2-
hTERT using custom-made quantitative PCR (qPCR) arrays.
We studied both cell lines before and after CDX2 transfection,
and with and without BMP4 stimulation. The qPCR results
confirmed higher expression levels of the columnar genes in
the BE samples as compared to the squamous biopsies, except
for K7, FABP6, and ACAT2. As expected, the expression of
squamous genes was higher in the squamous biopsies
(Figure 4A).
Expression levels of these genes showed similar patterns
between the squamous biopsies and the EPC2-hTERT cell
line. HET-1A cells lacked the expression of several squamous
markers such as CRNN, K13, and K5 (Figure S4B), confirming
that this cell line has an incomplete squamous phenotype
(Underwood et al., 2010). BMP4 stimulation of CDX2-transfected
and -nontransfected cells significantly downregulated the0, May 22, 2014 ª2014 The Authors 1201
Figure 5. BMP4 Modulates Squamous
Markers, whereas BMP4 and CDX2
Together Drive the Expression of MUC2
(A, C, and E) Western blot of primary keratino-
cytes, EPC2-hTERT, and HET-1A cells for
pSMAD, CDX2,MUC2, p63, K5, and K10/13 under
four conditions: control (unstimulated/un-
transfected) transfected with CDX2, stimulated
with BMP4 (100 ng/ml for 48 hr), transfected with
CDX2, and stimulated with BMP4 (see Figure S5
for IF of CDX2). Panels are representative of three
independent experiments and b-actin served as
loading controls.
(B, D, and F) IF forMUC2 (upper panels, green) and
K8 (lower panels, green) for the three cell lines
under the same four conditions. DAPI (blue) stains
the nuclei. See also Figures S5 and S6.squamous markers PPL, CRNN, and K13 in the EPC2-hTERT
cells, and PPL in HET-1A cells. In both cell lines, CDX2 transfec-
tion alone did not significantly affect the expression of any of the
markers including the putative CDX targets K20 andMUC2. Only
after stimulating the CDX2-transfected cells with BMP4, expres-
sion of K20 andMUC2was significantly upregulated (Figures 4B
and 4C) (McIntire et al., 2011; White et al., 2008). K20 was1202 Cell Reports 7, 1197–1210, May 22, 2014 ª2014 The Authorsrecently characterized as a putative
CDX1 target (Chan et al., 2009), but,
under certain conditions, CDX2 can sub-
stitute CDX1 function (Savory et al.,
2009). In contrast, MUC2 has been re-
ported as a direct target of CDX2 (Mes-
quita et al., 2003). K20 and MUC2 are
highly expressed in IM and are specific
markers for an intestinal phenotype.
Earlier, we and others showed that
BMP4 upregulates several columnar
genes (Milano et al., 2007; Wang et al.,
2010). Here, we have extended our earlier
findings and demonstrated that BMP4
also decreases the expression of several
squamous genes at the RNA level, and,
more importantly, we have found that
both CDX2 and BMP4 are required to
drive the expression of several specific
intestinal type of genes.
BMP4 Downregulates Squamous
Genes, whereas Both BMP4 and
CDX2 Are Required to Induce
MUC2 Protein Expression
To determine if the changes observed at
the gene expression level were translated
in protein expression, we analyzed pri-
mary cultures of mouse esophageal kera-
tinocytes, HET-1A, and EPC2-hTERT
cell lines by western blotting and immu-
nofluorescence (IF). The mouse esopha-
geal keratinocytes, EPC2-hTERT, andHET-1A cells showed efficient transfection of a CDX2-express-
ing vector (Figures 5A, 5C, 5E, and S5). In all cell lines, BMP4
activated the canonical BMP4/pSMAD pathway as indicated
by increased expression of pSMAD. This was seen regardless
of transfection with CDX2 (Figures 5A, 5C, and 5E). Activation
of the BMP4/pSMAD pathway in primary keratinocytes and
EPC2-hTERT cells induced downregulation of the squamous
markers p63, K5, and cytokeratin 10/13 (K10/13), whereas in
HET-1A both BMP4 and CDX2 were required to downregulate
K10/13 (Figures 5A, 5C, and 5E). Also independent of CDX2,
BMP4/pSMAD activation showed upregulation of the columnar
marker cytokeratin 8 (K8) in all three cell lines (Figures 5B, 5D,
and 5F). MUC2 expression was only slightly enhanced after
CDX2 transfection but increased significantly after stimulating
the CDX2-transfected cells with BMP4 (Figures 5A–5F). This
effect was best observed in the primary keratinocytes and
EPC2-hTERT, because they have the lowest endogenous levels
of pSMAD. In summary, our results confirm that BMP4 alone is
able to induce the expression of columnar proteins, whereas
downregulating the protein expression of several squamous
genes. Furthermore, we show that activation of the BMP4/
pSMADpathwaywith simultaneous CDX2 expression is required
to drive the expression of the intestinal specific gene MUC2.
Silencing of SMAD4 or CDX2 Decreases the Expression
Level of MUC2
Because both pSMAD and CDX2 are required to induce
squamous cells to express intestinal type of genes, we investi-
gated if disruption of one of these pathways would lead to an
opposite effect. First, we showed that Noggin (a natural BMP in-
hibitor) inhibits the canonical BMP/pSMADpathway and induces
downregulation of K8 (Figure 6A) in the BE cell line CP-A. Next,
we investigated if inhibiting the translocation of the SMAD4/
pSMAD complex to the nucleus would influence the expression
levels ofMUC2 in CDX2 competent cells. SMAD4 is essential for
translocation of pSMAD to the nucleus and for binding of the
pSMAD complex to gene promoters (ten Dijke et al., 2003).
The CP-A cells have a constitutively active pSMAD pathway
and express CDX2 and MUC2. Silencing SMAD4 using small
interfering RNA (siRNA) in these cells showed a significant reduc-
tion of MUC2 expression (Figure 6B). Similarly, silencing CDX2 in
CP-A cells downregulated the expression of MUC2 (Figure 6C).
These findings confirm that CDX2 regulates expression of
MUC2 (Mesquita et al., 2003; Ikeda et al., 2007; Yamamoto
et al., 2003), but here we demonstrated that MUC2 expression
also depends on BMP4 downstream signaling.
pSMAD and CDX2 Form a Transcriptional Complex that
Binds to themuc2 Promoter and Is Required for MUC2
Expression
To evaluate if pSMAD and CDX2 interact, coimmunoprecipita-
tion (coIP) was performed on lysates of HET-1A cells transfected
with CDX2 and stimulated with BMP4, and CP-A cells that
endogenously express pSMAD and CDX2. Precipitation of
pSMAD, using a CDX2-specific antibody (Figures 6D and 6E)
was observed in both cell lysates. These findings unveil a direct
interaction between pSMAD and CDX2. Sequence analysis also
revealed the presence of a SMAD binding site, GTCT Smad box
(Shi et al., 1998), within the CDX2 binding site of the muc2
promoter. To investigate if the complex consisting of pSMAD
and CDX2 indeed binds to the muc2 gene promoter, chromatin
immunoprecipitation (ChIP) was performed in HET-1A cells
transfected with CDX2 and stimulated with BMP4. We found
that the CDX2 binding region of themuc2 promoter was enriched
in the precipitated chromatin when using an antibody againstCpSMAD, and, as expected, when using an antibody against
CDX2 (Figures 6F and 6H). Similar results were observed for
human BE biopsy lysates (Figure 6H). Further evidence that
CDX2 and pSMAD simultaneously engage the muc2 promoter
was obtained from the re-ChIP experiments, in which by sequen-
tially using antibodies against pSMAD and CDX2 we again
showed the pull-down of the same CDX2 binding region of the
muc2 promoter in the precipitated chromatin (Figures 6G and 6I).
In summary, we found that pSMAD and CDX2 are part of one
transcriptional complex, which targets the samemuc2 gene pro-
moter region.
CDX2 and BMP4/pSMAD activation Induce
Ultrastructural Changes in Mouse Primary
Keratinocytes
We studied ultrastructural changes in mouse primary keratino-
cytes, before and after transfection with CDX2 and/or exposure
to BMP4. By transmission electron microscopy (TEM), resting
untreated primary keratinocytes cells were multilayered polyg-
onal, flattened cells (Figures 7i and ii), attached to each other
via multiple attachment sites. The cells had disc-shaped, cen-
trally placed nuclei, with perinuclear organized keratins and
irregular finger-like cytoplasmic extensions surrounding them
(Figures 7i and ii). These features are consistent with the normal
ultrastructural appearance of squamous cells (Zboralske and
Karasek, 1984). After BMP4 stimulation, the multilayered cellular
organization was lost in favor of a single cell layer with flattened
nuclei (Figure 7iii), and a few vacuoles within the cytoplasm (Fig-
ure 7iv). Primary keratinocytes transfected with CDX2 retained a
multilayered appearance with abundant keratin (Figure 7v) and
showed several cytoplasmic vacuoles and more abundant
cellular extensions (Figures 7v and vi). CDX2-transfected cells
exposed to BMP4 showed the formation of a single cellular layer,
similar to the cells stimulated with BMP4 alone (Figures 7vii and
viii). The cells contain numerous secretory vesicle-like struc-
tures. Richardson staining (Richardson et al., 1960) on epoxy
semithin sections of primary mouse epithelial keratinocytes
showed vacuoles that stain positive for methylene blue, a
cationic dye that binds tissue anions such as ionized sulfate
groups in mucins (Figure S7C). These cells also had shorter
cellular extensions regularly organized at the cell surface, which
resemble the formation of microvilli (Figures 7vii and viii). Noggin
pretreatment of the CDX2-transfected/BMP4-treated cells
prevented the BMP4 effects and retained the multi layered
appearance (Figures 7ix and x). The EM results indicate that
the combination of CDX2 transfection and BMP4/pSMAD
pathway activation in vitro induces changes at the ultrastructural
level toward a columnar-like phenotype.
DISCUSSION
The complex interplay between the BMP4/pSMAD pathway and
its antagonists is essential for the development and homeostasis
of the esophageal epithelium (Que et al., 2006; Rodriguez et al.,
2010). It was earlier shown that the nonintestinal type of
columnar esophageal metaplasia involves deregulation of this
pathway but was insufficient for development of the more malig-
nant intestinal type of BE (Wang et al., 2010; Milano et al., 2007).ell Reports 7, 1197–1210, May 22, 2014 ª2014 The Authors 1203
(legend on next page)
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Here, we showed that BMP4-overexpressing transgenic mice
developed columnar cells restricted to the SCJ. The constitutive
overexpression of BMP4 in the K14-BMP4 mice seems to
enhance the expression of inhibitory molecules such as Noggin
compensating the BMP4 effects in proximal part of the esoph-
agus (Figures S1A and S1B). Tissue homeostasis at junctions
is complex and maintained by environmental factors, which
regulate cell and tissue type (Slack, 2007). In the K14-BMP4
mice, the conflicting signals of the normal columnar stomach
epithelium and the signals of the squamous epithelium favored
the development of columnar metaplasia at the SCJ. Thus, at
the SCJ, the environment seems to serve as a niche for (stem)
cells either originating from squamous or from the columnar
epithelium to give rise to metaplastic glands. The K14-BMP4
model did not account for the effects of bile reflux as observed
in Barrett’s patients (Quante et al., 2012; Huo et al., 2010; Kazu-
mori et al., 2006). Bile acids have shown to induce intestinal
factors such as CDX2 and MUC2 in gastric epithelial cells (Xu
et al., 2010). Earlier overexpression of CDX2 in themouse esoph-
agus under the k14 promoter failed to induce columnar meta-
plasia (Kong et al., 2011). The surgical model allowed us to
identify the sequence in which various markers appear during
the development of nonintestinal and intestinal metaplasia. We
demonstrated that activation of the BMP4/pSMAD pathway is
an early event, whereas CDX2 and MUC2 expression appear
late during the development of IM. In several cell lines, we
show that both factors are required to drive the expression of
MUC2, which is one of the most characteristic intestinal marker.
We demonstrated that these two factors form a functional com-
plex, which binds to the muc2 gene promoter. Based on these
findings we propose that metaplastic columnar cells can differ-
entiate further into specialized intestinal type of cells, and the
pSMAD/CDX2 interaction plays a crucial role in this process. In
the chromatin immunoprecipitation experiments on human BE
cells, we confirmed at the molecular level that both CDX2 and
pSMAD bind to the muc2 gene promoter. Thus, in human BE,
both factors are involved for the induction of MUC2 expression
(Figure 6H). Besides the changes induced at the molecular level,
in vitro, the plasticity of the mouse keratinocytes was alsoFigure 6. CoIP and ChIP Indicate that pSMAD and CDX2 Form a Trans
(A) Expression of K8 by IF in the CP-A BE cell line after Noggin (100 ng/ml) treat
(B) Quantification of SMAD4 andMUC2 levels by western blot analysis of CP-A ce
relative expression levels of SMAD4 and MUC2 are normalized to b-actin. Repres
the SEM of the mean, paired t test *p < 0.05, **p < 0.01, n = 3.
(C) Quantification of CDX2 andMUC2mRNA relative expression in CP-A BE cells
RT-PCR data were normalized to the expression level of GAPDH. Error bar indic
(D and E) CoIP of HET-1A cells transfected with CDX2 and stimulated with BMP4
HET-1A only transfected with CDX2 (HET-1A/CDX2), and CP-A cells. Whole-cell
immunoblotted (IB) with a pSMAD antibody.
(F) Representative RT-PCR image of chromatin immunoprecipitation (ChIP) expe
taken as a positive control. Immunoglobulin (Ig) G and no antibody (No Ab) were
(G) Representative RT-PCR image of the Re-ChIP experiment on HET-1A/CDX2
bodies for pSMAD and CDX2.
(H) Quantification of the MUC2 signal from three different ChIP experiments carrie
treated with BMP4 (+CDX2+BMP4) and in biopsies from BE patients using pSM
mean, unpaired t test *p < 0.05, n = 3.
(I) Quantification of the Re-ChiP on HET-1A/CDX2+BMP4 cells shows enrichme
pSMAD and CDX2 antibodies sequentially as compared to the IgG control.
Error bar indicates the SEM, unpaired t test *p < 0.05, n = 3.
Cdemonstrated at the ultrastructural level. We showed that the
keratinocytes lost their multilayered appearance and reorgan-
ized into a monolayer, whereas the cells developed features
such as microvilli when both CDX2 and pSMAD activation
were induced.
Thus in vitro aberrant activation of the pSMAD/CDX2 tran-
scriptional pathway in squamous cells leads to columnar reprog-
ramming. However, the precise phenotypic characteristics of
cells that give rise to Barrett’s metaplasia in vivo still remains
to be elucidated.
In humans, besides the IM recognized in the distal esophagus,
metaplasia can also develop in the proximal tubular esophagus,
e.g., in patients who have undergone esophagocardia resection
(Castillo et al., 2012), or in the gastric cardia (Sharma et al., 2004).
It is possible that each of these different organ sites involve
different progenitors. In humans, the presence of the samemito-
chondrial mutations in squamous mucosa and BE imply a com-
mon stem cell for squamous andBE cells (Nicholson et al., 2012).
The human esophageal epithelium contains complex structures
such as submucosal glandular structures, which may contain
different (stem) cell lineages (Glickman et al., 2001b) and is
more complex than the mouse epithelium. In mice, it has been
recently shown that virtually all basal cells through stochastic
divisions serve as squamous progenitors (Doupe´ et al., 2012),
whereas human squamous cells at different stages of differenti-
ation were found to have self-renewal capacity (Barbera et al.,
2014).
In an interleukin (IL)-1b-overexpressing model, it has been
suggested that columnar metaplasia at the SCJ is derived from
Lgr5+ progenitors (Quante et al., 2012). The lineage tracing ex-
periments in the surgical model in our study, which develops
metaplasia in the mid-esophagus was, however, negative for
Lgr5. Analysis of progenitor cells in different mouse models
might result in conflicting outcomes, which might be dependent
on the location of themetaplasia, explaining the divergent results
with our Lgr5+ lineage tracing experiments. Mouse models may
support important observations that occur during the develop-
ment of metaplasia. But these models will always fall short in de-
ciphering the origin of the human Barrett’s progenitor cell,criptional Complex Required for MUC2 Expression
ment for 5 days (10x magnified).
lls lysates transfected with or without SMAD4 siRNA and nontarget siRNA. The
entative western blot and IF panels are shown in Figure S7. Error bars indicate
after siRNA-mediated knockdown of CDX2. siRNA nontarget control is shown.
ates the SEM of the mean, paired t test **p < 0.01, n = 3.
(HET-1A/CDX2+BMP4), HET-1A only stimulated with BMP4 (HET-1A+BMP4),
lysates were immunoprecipitated (IP) with a pSMAD or a CDX2 antibody and
riments on nuclear extracts of HET-1A+BMP4 and HET-1A/CDX2. Input was
taken as negative controls.
+BMP4 cells, where the chromatin is precipitated by subsequently using anti-
d out in HET-1A cells transfected with CDX2 alone (+CDX2) or transfected and
AD and CDX2 antibodies and IgG controls. Error bars indicate the SEM of the
nt of the CDX2 binding region of the muc2 gene promoter obtained by using
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because of the fundamental anatomical differences between the
human and mouse esophagus. Indeed characterizing the
Barrett’s progenitor cell is complex and will require analysis of
human metaplastic cell populations to reveal distinct progenitor
cell phenotypes. In such analyses, one will need to take into
account that BE is a preneoplastic lesion acquired during adult-
hood. Therefore, it is possible that compared to embryonic stem
cells, the Barrett’s progenitor cells may present a mixed signa-
ture and for instance may also carry cancer (stem) cell features.
The Barrett’s preneoplastic progenitors may, for instance,
resemble the more recently discovered ‘‘endogenous pluripo-
tent somatic cell’’ (ePSC), identified in adult human mammary
tissue, which showed to have lineage plasticity comparable to
embryonic stem cells (Roy et al., 2013).
Several studies have identified other transcription factors such
as SOX9, CDX1, KLF4, GATA6, HOX genes to be involved in the
development of BE (Clemons et al., 2012; Kazumori et al., 2009,
2011; Wang et al., 2010; van Baal et al., 2013; di Pietro et al.,
2012). We believe that this transcriptional complex may not be
exclusive to pSMAD/CDX2 but may also involve several of the
above-mentioned factors. Our findings provide important insight
in the development of the premalignant intestinal type of differ-
entiation. Intestinal type of metaplasia is at the basis of several
malignancies (Barros et al., 2012; Spechler et al., 2010). Target-
ing the interaction of CDX2 and pSMAD could be an interesting
strategy to reverse intestinal metaplasia in order to prevent
development of the highly malignant adenocarcinoma.EXPERIMENTAL PROCEDURES
Human Biopsy Specimens and Sampling
Informed consent and institutional ethical permission were obtained for the
use of patient’s biopsies. Full details about the biopsies can be found in Sup-
plemental Experimental Procedures.
Generation of K14-BMP4 Transgenic Mice
The transgenic mice were obtained from Dr. Kessler at Northwestern Univer-
sity Medical School and were generated as described elsewhere (Guha
et al., 2002).
Barrett’s Mouse Model
Twelve CB6F1male mice were used after formal approval of the animal ethical
committee of the study. The surgical technique for inducing the esophagojeju-
nostomy to induce reflux and metaplasia is described in Supplemental Exper-
imental Procedures. For this study, animals were sacrificed 6, 12, and
16 weeks after the operation. Tissues of the anastomosis site were formalin
fixed and paraffin embedded for IHC.Figure 7. Ultrastructural Changes in Primary Mouse Keratinocytes by
(Ai and Aii) Primary cultures of mouse keratinocytes display amultilayered organiz
attachments (Aii, arrows).
(Aiii and Aiv) Primary keratinocytes treated with BMP4 (100 ng/ml for 5 days) sh
arrows).
(Av and Avi) Cells transfected with CDX2 show a multilayered organization, dense
elongated cellular extensions (Avi, open arrows).
(Avii and viii) After CDX2 transfection and BMP4 stimulation the cells are organize
microvilli-like structures (open arrows) on the cell surface.
(Aix and Ax) Cells treatedwith Noggin, before CDX2 transfection andBMP4 stimula
to the cells transfected with CDX2 (Av and Avi).
See also Figure S7.
CIn Situ Hybridization
In situ hybridization (ISH) for Lgr5 was carried out as described previously
(Barker et al., 2007). Full details can be found in Supplemental Experimental
Procedures.
Lgr5 Lineage Tracing
Lgr5-eGFP-ires-CreERT2 mice (Barker et al., 2007) were crossed with mice
carrying the Rosa26LacZ reporter allele. Eight-week- old mice were injected
intraperitoneally with 200 ml Tamoxifen in sunflower oil at 10 mg/ml. The surgi-
cal technique is described in Supplemental Experimental Procedures. Animals
were sacrificed 6, 12, and 16 weeks after the operation. Tissues of the anas-
tomosis site were stained for X-gal, fixed in 4% PFA overnight, and paraffin
embedded.
Antibodies
All the antibodies used for the different procedures are listed in Table S1. The
antimurine MUC2 antibody as characterized by Prof. J. Dekker (van Klinken
et al., 1999) was kindly provided by the Erasmus University of Rotterdam.
Cell Cultures
The human SV40-T antigen immortalized esophageal epithelial cell line HET-
1A was purchased from ATCC. The human hTERT immortalized esophageal
cell line, EPC2-hTERT, was a kind gift of Prof. A. Rustgi, University of Pennsyl-
vania (Harada et al., 2003). The BE cell line CP-A was provided by Dr. R. Fitz-
gerald (Cambridge, UK) and used with permission of Prof. P.S. Rabinovitch
(Palanca-Wessels et al., 2003). Normal murine esophageal primary keratino-
cytes cultures were established following the protocol of J. Kalabis (Kalabis
et al., 2012). Full details about the culturing methods can be found in Supple-
mental Experimental Procedures.
Transfection of Cells
Transfection of the cell lines was carried out as described previously (Milano
et al., 2007). Full details are provided in Supplemental Experimental
Procedures.
Immunohistochemistry and Immunofluorescence
Detailed IHC and IF protocols are provided in Supplemental Experimental
Procedures.
RNA Isolation, RT-PCR, and Quantitative Real-Time PCR Arrays
RNA isolation was carried out as described elsewhere (Milano et al., 2007). RT-
PCR was performed using the primers and conditions provided in Supple-
mental Experimental Procedures. Real-time qPCR was performed using
customized RT2 Profiler PCR arrays (SABiosciences) on the Roche Light
Cycler 480 using RT2 SYBR Green/qPCR Master Mix (SABiosciences). Data
were normalized to the expression level of hypoxanthine phosphoribosyltrans-
ferase 1 (HPRT1). Full details can be found in Supplemental Experimental
Procedures.
Western Blot Analysis
EPC2-hTERT and EPC2-hTERT/CDX2, HET-1A and HET-1A/CDX2, primary
keratinocytes and primary keratinocytes/CDX2 cells were exposed toTransmission Electron Microscopy
ation with perinuclear keratin deposits (Ai, arrows) andmultiple irregular cellular
ow a single layered organization, a flat cellular shape and few vacuoles (Aiv,
keratin deposits (Av, open arrows), cytoplasmic vacuoles (closed arrows) and
d in single layer and show several secretory-like vacuoles (closed arrows) and
tion, retain amultilayered organization, showing similar ultrastructural changes
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100 ng/ml BMP4 for 48 hr or left untreated. Protein lysates were processed as
described earlier (Milano et al., 2007). Further details can be found in Supple-
mental Experimental Procedures.
RNA interference
CP-A cells were processed as previously described (Vincent et al., 2009).
siRNA against SMAD4, siRNA against CDX2 and the corresponding scrambled
siRNAs were used. See Supplemental Experimental Procedures for details.
Coimmunoprecipitation
Proteins were subjected to coimmunoprecipitation using a coIP kit (Pierce)
and processed as previously described (Vincent et al., 2009). Details can be
found in Supplemental Experimental Procedures.
Chromatin Immunoprecipitation
The ChIP assay and the Re-ChIP assay were performed as previously
described (Sinkkonen et al., 2005; Bunt et al., 2010). A detailed description
of the procedures is provided in Supplemental Experimental Procedures.
Transmission Electron Microscopy
Samples used for transmission electron microscopy (TEM) were processed
using standard techniques. A detailed protocol can be found in Supplemental
Experimental Procedures.
Statistical Analysis of Data
All experimentswere repeated at least three times on independently generated
samples. Representative experiments or the quantitative densitometric anal-
ysis of several experiments are shown. Data are presented as mean ± SEM
and were evaluated using indicated statistical tests on Prism 5.0 software
(GraphPad). A value of p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.03.074.
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